News and Trends 5 Nov 2018
Series C Bags German Company €17M for Irregular Heartbeat Treatment
Omeicos Therapeutics has secured €17M in a Series C round to fund clinical development of its lead treatment for irregular heartbeat. Robert Fischer, CEO of the German biopharmaceutical company, told…